Eventide Asset Management, LLC Cidara Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$4.0 - $8.15 $688,000 - $1.4 Million	-172,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$6.35 - $8.75 $584,200 - $805,000	-92,000 Reduced 34.85%	172,000 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $1.52 Million - $2.14 Million	264,000	264,000 $2.14 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.